Clinical trial
Combination Chemotherapy With or Without SU5416 in Treating Patients With…
NCT00021281 · Jonsson Comprehensive Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00021281 |
|---|---|
| Title | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer |
| Official title | A Phase III, Randomized, Open-Label Multicenter, International Study Comparing The Combination Of SU5416/Irinotecan/5-Fluorouracil/Leucovorin Versus Irinotecan/Fluorouracil/Leucovorin Alone As First-Line Therapy Of Patient With Previously Untreated Metastatic Colorectal Cancer |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFIRI regimen, fluorouracil, irinotecan hydrochloride, leucovorin calcium, semaxanib |
| Start date | Dec 1, 2000 |
| First posted | Apr 13, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: